Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status

Cancer

Volumn 119, Issue 18, 2013, Pages 3302-3308

  Maxwell, Jessica H ^a   Ferris, Robert L ^a   Gooding, William ^b   Cunningham, Diana ^b   Mehta, Vikas ^c   Kim, Seungwon ^a   Myers, Eugene N ^a   Johnson, Jonas ^a   Chiosea, Simion ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Extracapsular spread; HPV; oral cavity; p16, oropharynx; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; EXTRACAPSULAR SPREAD; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; WART VIRUS;

EXTRACAPSULAR SPREAD; HPV; ORAL CAVITY; P16, OROPHARYNX; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883599558     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28169     Document Type: Article

References (30)

1. Johnson JT, Barnes EL, Myers EN, Schramm VL Jr, Borochovitz D, Sigler BA,. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 1981; 107: 725-729. (Pubitemid 12245989)
2. Ferlito A, Rinaldo A, Devaney KO, et al. Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol. 2002; 38: 747-751. (Pubitemid 36254701)
3. Carter RL, Barr L.C, O'Brien CJ, Soo KC, Shaw HJ,. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg. 1985 (150): 495-499.
4. Alvi A, Johnson JT,. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck. 1997; 19: 500-505. (Pubitemid 27349669)
5. Myers JN, Greenberg JS, Mo V, Roberts D,. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001; 92: 3030-3036. (Pubitemid 33136197)
6. Vaidya AM, Petruzzelli GJ, Clark J, Emami B,. Patterns of spread in recurrent head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2001; 125: 393-396. (Pubitemid 33661067)
7. Greenberg JS, Fowler R, Gomez J, et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 2003; 97: 1464-1470. (Pubitemid 36297776)
8. Jan JC, Hsu WH, Liu SA, et al. Prognostic factors in patients with buccal squamous cell carcinoma: 10-year experience. J Oral Maxillofac Surg. 2011; 69: 396-404.
9. Shaw RJ, Lowe D, Woolgar JA, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck. 2010; 32: 714-722.
10. Myers EN, Alvi A,. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope. 1996; 106: 559-567. (Pubitemid 26137833)
11. Liu B, Guan C, Ji WY, Pan ZM,. Extracapsular spread in ipsilateral neck metastasis: an important prognostic factor in laryngeal cancer. Chin Med Sci J. 2006; 21: 86-89. (Pubitemid 44023216)
12. Wenzel S, Sagowski C, Kehrl W, Metternich FU,. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2004; 261: 270-275. (Pubitemid 38680325)
13. Klozar J, Kratochvil V, Salakova M, et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2008; 265 (suppl 1): S75-S82.
14. Shimizu K, Inoue H, Saitoh M, et al. Distribution and impact of lymph node metastases in oropharyngeal cancer. Acta Otolaryngol. 2006; 126: 872-877. (Pubitemid 44091771)
15. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100: 407-420. (Pubitemid 351480511)
16. Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010; 16: 1226-1235.
17. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-269. (Pubitemid 351480538)
18. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
19. Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH,. Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol. 2011; 24: 1413-1420.
20. Sinha P, Lewis JS Jr, Piccirillo JF, Kallogjeri D, Haughey BH,. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer. 2012; 118: 3519-3530.
21. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
22. Chenevert J, Chiosea S,. Incidence of human papillomavirus in oropharyngeal squamous cell carcinomas: now and 50 years ago. Hum Pathol. 2012; 43: 17-22.
23. Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
24. Singhi AD, Westra WH,. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010; 116: 2166-2173.
25. D'Souza G, Dempsey A,. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011; 53 (suppl 1): S5-S11.
26. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL Jr, Thearle PB,. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol. 1985; 111: 534-537. (Pubitemid 15249730)
27. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27: 843-850. (Pubitemid 41395696)
28. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; 350: 1937-1944.
29. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004; 350: 1945-1952. (Pubitemid 38580197)
30. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349: 2091-2098. (Pubitemid 37464533)